tiprankstipranks
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market
Holding ARQT?
Track your performance easily

Arcutis Biotherapeutics (ARQT) Financial Statements

744 Followers

Arcutis Biotherapeutics Financial Overview

Arcutis Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-1.792; its P/E ratio is -8.36; Arcutis Biotherapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 44.76M$ 30.86M$ 49.57M$ 13.53M$ 38.11M
Gross Profit$ 39.25M$ 27.39M$ 46.31M$ 11.28M$ 36.93M
EBIT$ -41.54M$ -52.33M$ -27.58M$ -58.50M$ -34.18M
EBITDA$ -40.03M$ -50.13M$ -27.12M$ -58.11M$ -33.80M
Net Income Common Stockholders$ -41.54M$ -52.33M$ -35.38M$ -66.28M$ -44.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 330.56M$ 362.44M$ 403.87M$ 271.86M$ 227.11M
Total Assets$ 437.35M$ 444.76M$ 478.54M$ 341.37M$ 292.96M
Total Debt$ 208.18M$ 207.56M$ 206.74M$ 205.92M$ 205.07M
Net Debt$ -122.38M$ -154.87M$ -197.13M$ -65.94M$ -22.05M
Total Liabilities$ 280.71M$ 258.33M$ 253.60M$ 252.70M$ 246.24M
Stockholders Equity$ 156.64M$ 186.43M$ 224.94M$ 88.67M$ 46.72M
Cash Flow-
Free Cash Flow$ -34.83M$ -45.12M$ -31.60M$ -56.25M$ -44.05M
Operating Cash Flow$ -34.69M$ -45.12M$ -31.60M$ -56.24M$ -43.98M
Investing Cash Flow$ 84.78M$ -62.14M$ -28.70M$ -62.19M$ 45.55M
Financing Cash Flow$ 394.00K$ 1.46M$ 161.76M$ 99.29M$ 867.00K
Currency in USD

Arcutis Biotherapeutics Earnings and Revenue History

Arcutis Biotherapeutics Debt to Assets

Arcutis Biotherapeutics Cash Flow

Arcutis Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis